Literature DB >> 23322740

Influence of the amount of myocardium subtended by a stenosis on fractional flow reserve.

Antonio Maria Leone1, Alberto Ranieri De Caterina, Eloisa Basile, Andrea Gardi, Domenico Laezza, Mario Attilio Mazzari, Rocco Mongiardo, Rajesh Kharbanda, Florim Cuculi, Italo Porto, Giampaolo Niccoli, Francesco Burzotta, Carlo Trani, Adrian Paul Banning, Antonio Giuseppe Rebuzzi, Filippo Crea.   

Abstract

BACKGROUND: Fractional flow reserve (FFR) specifically relates to the severity of a stenosis to the mass of tissue to be perfused. Accordingly, the larger the territory to be perfused, the greater the flow and the pressure gradient induced by maximal hyperemia. Although this notion may be considered intuitive, its unequivocal demonstration is still lacking. The aim of our study was to evaluate the influence of the amount of myocardium subtended to an intermediate stenosis on FFR, especially in relation to quantitative coronary angiography. METHODS AND
RESULTS: The severity of each lesion was assessed by FFR and 2-dimensional quantitative coronary angiography. The amount of jeopardized myocardium was evaluated using 3 validated scores specifically adapted to this aim: the Duke Jeopardy Score (DJS), the Myocardial Jeopardy Index (MJI), and the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease (APPROACH) Lesion Score (ALS). The presence of a concomitant collateralized chronic total occlusion was also reported. A total of 213 intermediate coronary stenoses in 184 patients were enrolled. FFR values were correlated to minimal lumen diameter (r=0.34; P<0.0001) and diameter stenosis (r=-0.28; P<0.0001). FFR was inversely correlated with DJS, MJI, and ALS (r=-0.28, P<0.0001; r=-0.40, P<0.0001; and r=-0.34, P<0.0001). Lesions localized on proximal left anterior descending were related to significantly lower FFR values and to a higher rate of a positive FFR compared with those in distal left anterior descending, left circumflex, and right coronary arteries (0.80±0.09 versus 0.84±0.08 versus 0.88±0.09 versus 0.91±0.04; P<0.0001). The presence of a collateralized chronic total occlusion was associated with significantly lower FFR values (0.80±0.07 versus 0.85±0.09; P<0.005). At multivariate analysis MJI, minimal lumen diameter, and presence of a collateralized chronic total occlusion were confirmed as significant predictors of FFR.
CONCLUSIONS: A larger amount of perfused myocardium subtended by a stenosis is associated with a higher probability that an angiographically intermediate coronary stenosis is functionally significant.

Entities:  

Mesh:

Year:  2013        PMID: 23322740     DOI: 10.1161/CIRCINTERVENTIONS.112.971101

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN: 1941-7640            Impact factor:   6.546


  19 in total

Review 1.  The Role of Fractional Flow Reserve and Instantaneous Wave-Free Ratio Measurements in Patients with Acute Coronary Syndrome.

Authors:  Abdul Rahman Ihdayhid; Jin-Sin Koh; John Ramzy; Arnav Kumar; Michael Michail; Adam Brown; Habib Samady
Journal:  Curr Cardiol Rep       Date:  2019-11-25       Impact factor: 2.931

2.  Real-world use of fractional flow reserve in Germany: results of the prospective ALKK coronary angiography and PCI registry.

Authors:  Tobias Härle; Uwe Zeymer; Matthias Hochadel; Ralf Zahn; Sebastian Kerber; Bernhard Zrenner; Volker Schächinger; Bernward Lauer; Thorsten Runde; Albrecht Elsässer
Journal:  Clin Res Cardiol       Date:  2016-09-06       Impact factor: 5.460

3.  Intracoronary pressure measurement differences between anterior and posterior coronary territories.

Authors:  T Härle; S Meyer; W Bojara; F Vahldiek; A Elsässer
Journal:  Herz       Date:  2016-08-31       Impact factor: 1.443

4.  The best predictor of ischemic coronary stenosis: subtended myocardial volume, machine learning-based FFRCT, or high-risk plaque features?

Authors:  Mengmeng Yu; Zhigang Lu; Chengxing Shen; Jing Yan; Yining Wang; Bin Lu; Jiayin Zhang
Journal:  Eur Radiol       Date:  2019-03-22       Impact factor: 5.315

5.  Accuracy of 3-dimensional and 2-dimensional quantitative coronary angiography for predicting physiological significance of coronary stenosis: a FAVOR II substudy.

Authors:  Daixin Ding; Junqing Yang; Jelmer Westra; Yundai Chen; Yunxiao Chang; Martin Sejr-Hansen; Su Zhang; Evald H Christiansen; Niels R Holm; Bo Xu; Shengxian Tu
Journal:  Cardiovasc Diagn Ther       Date:  2019-10

6.  Characteristics of function-anatomy mismatch in patients with coronary artery disease.

Authors:  Hyun-Ok Cho; Chang-Wook Nam; Yun-Kyeong Cho; Hyuck-Jun Yoon; Hyoung-Seob Park; Hyungseop Kim; In-Sung Chung; Joon-Hyung Doh; Bon-Kwon Koo; Dae-Woo Hyun; Seung-Ho Hur; Yoon-Nyun Kim; Kwon-Bae Kim
Journal:  Korean Circ J       Date:  2014-11-25       Impact factor: 3.243

Review 7.  Fractional flow reserve-guided management in stable coronary disease and acute myocardial infarction: recent developments.

Authors:  Colin Berry; David Corcoran; Barry Hennigan; Stuart Watkins; Jamie Layland; Keith G Oldroyd
Journal:  Eur Heart J       Date:  2015-06-02       Impact factor: 29.983

Review 8.  The evidence base for revascularisation of chronic total occlusions.

Authors:  Alan Bagnall; Ioakim Spyridopoulos
Journal:  Curr Cardiol Rev       Date:  2014-05

9.  How does coronary stent implantation impact on the status of the microcirculation during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction?

Authors:  Giovanni Luigi De Maria; Florim Cuculi; Niket Patel; Sam Dawkins; Gregor Fahrni; George Kassimis; Robin P Choudhury; John C Forfar; Bernard D Prendergast; Keith M Channon; Rajesh K Kharbanda; Adrian P Banning
Journal:  Eur Heart J       Date:  2015-08-07       Impact factor: 29.983

10.  The Same Angiographic Factors Predict Venous and Arterial Graft Patency: A Retrospective Study.

Authors:  Mario Gaudino; Giampaolo Niccoli; Marco Roberto; Federico Cammertoni; Nicola Cosentino; Elena Falcioni; Mario Panebianco; Domenico D'Amario; Filippo Crea; Massimo Massetti
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.